Financial Services

After a banner 2025, TriMas is selling its aerospace unit to double down on packaging, armed with a major cash infusion and a new efficiency plan.

A massive funding allocation aims to tackle the housing crisis with downpayment aid, development grants, and a unique focus on protecting generational wealth.

As AI hiring tools face scrutiny for bias, WorkWhile's new platform uses AI to uncover worker skills and build careers, not just screen applicants.

The Singaporean facilities firm lands major residential deals, bolstering its recurring revenue as it navigates financial headwinds with a push in AI robotics.

A new 100% fiber-optic network is coming to Antioch, Grayslake, and Winthrop Harbor, promising more speed and choice in a competitive market.

A new order extends a decade-long partnership, highlighting CPI Aero's key role in the supply chain of Embraer's best-selling Phenom 300 business jet.

Love's Travel Stops overhauls its loyalty program, unifying rewards for all drivers in a digital-first push to win the battle for the roadside.

With a new VP of Brand Partnerships, Solésence aims to leverage its science-first platform to help beauty brands accelerate speed to market.

The fitness giant opened 365+ clubs in a stunning global expansion. Now, with new leadership, Purpose Brands aims to conquer the domestic market.

Nautilus Biotechnology cuts losses and preps its Voyager platform for a late 2026 launch, targeting the next frontier in neurodegenerative disease research.

As AOUT prepares its Q3 results, investors seek signs of resilience in a tough market. Can its innovation pipeline offset cautious consumer spending?

Cannara Biotech's graduation to the TSX, backed by strong financials and new analyst coverage, marks a pivotal moment for the company and the cannabis sector.

Infrastructure software giant posts 11% revenue growth, outlines a bullish 2026 forecast, and doubles down on AI with key acquisitions.

Palmer Square Capital BDC reports a drop in 2025 income and asset value but highlights rock-solid credit quality and an optimistic outlook for 2026.

A new partnership brings AI to customs, promising to help U.S. importers reclaim millions in overpaid duties and navigate volatile global trade.

Spectral Medical shifts its FDA submission for a breakthrough sepsis device, a strategic move that could strengthen its case but delays a potential lifeline.

On the war's fourth anniversary, Kyivstar's board, including Mike Pompeo, visited Kyiv, reaffirming a $1B investment and honoring resilient employees.

Nuveen Churchill Direct Lending Corp. adjusts its shareholder return strategy in response to a changing interest rate and spread environment.

Former USAA CEO Wayne Peacock joins Cotality's board, signaling a strategic push to lead the AI-driven property data and insurance analytics market.

With a key FDA decision looming and pivotal data on a second therapy imminent, Viridian is poised to reshape the multi-billion dollar Thyroid Eye Disease market.